NEWSROOM

PAOG

PURA Aims To Modestly Extract $10 Million This Year From $18 Billion Hemp Industry Establishing A Foothold In A Much Larger Opportunity

Dallas, TX, Jan. 18, 2022 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today published a 2022 strategic management overview of the company’s plan for an anticipated $1 million in revenue with the potential to reach $10 million in revenue this year. The overview published today will be followed up over the next several weeks with additional management presentations covering more detail on each of the major overview components highlighted in the presentation below: Driving Demand For The...

read more

PAOG Confirms Farmersville Hemp Brand CBD Product Line Development For PURA

    Sandusky, OH, Jan. 06, 2022  -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed the development of a line of CBD nutraceutical products for Puration, Inc. (OTC Pink: PURA) is underway. PURA has updated its business model over the course of the last year and is now focusing on the development of a hemp business cooperative under the brand name Farmersville Hemp. PURA has established its new business model to build an industrial hemp business with 3 sources of...

read more

PURA Revenue Model Comes Into Focus As Company Pursues $18 Billion Hemp Market

Dallas, Texas, Dec. 16, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today confirmed a 2022 $1 million revenue forecast for its hemp business with a revenue upside potential to $10 million by year end 2022. PURA is targeting the industrial hemp market with a cooperative branding strategy founded largely on hemp’s potential sustainability impact. PURA has established a new business model to build an industrial hemp business with 3 sources of revenue – education, branding and...

read more

PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision

    Sandusky, OH, Dec. 15, 2021 -- McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s line of “RX” branded full-spectrum CBD products are now available for sale at www.usmj.com. PAOG is developing both pharmaceutical and nutraceutical treatments based on its own proprietary extraction technology. The RX branded products are PAOG’s first nutraceutical products. The RX branded products have been well received and are now available for sale direct to...

read more

PURA Sustainable Farmersville Hemp Brand Bolstered By USASU $0.10-0.15 Net Profit Per Share Projection

  Dallas, TX, Dec. 10, 2021 -- McapMediaWire - Puration, Inc. (OTC Pink: PURA) today highlighted the strength of its cannabis real estate finance partner, UC Asset LP (OTCQX: UCASU). UCASU has announced a projected $0.10 to $0.15 net profit per share to be reported for year end 2021.  UCASU is financing the construction of PURA’s hemp university facility in Farmersville, Texas and has agreed to back PURA Farmersville Hemp Brand Partners cannabis real estate projects. PURA is targeting the...

read more

PURA Farmersville Hemp Targets $13B CBD Market And $41B Sustainability Market

Dallas, Texas, Dec. 06, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today highlighted that while the CBD market is anticipated to grow to $13 billion by 2028, the Green Technology and Sustainability Market expected to expand from $9 billion reported in 2021 to over $41 billion by 2028. PURA has launched its Farmersville Hemp brand to expand the overall market opportunity for hemp by first providing education on the overall potential of industrial hemp.  In addition to generating...

read more

PURA and PAOG Announce CBD IP Deal In Conjunction With New CBD Infused Product Developments

  Sandusky, OH, Dec. 03, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) announced the closing of a transaction today whereby PAOG has acquired an exclusive license to a patented cannabis extraction process from PURA that will expand PAOG’s existing CBD intellectual property. Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). ...

read more

PURA and PAOG Confirm CBD IP Deal Schedule To Close Friday

  Sandusky, OH, Dec. 01, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) today confirmed the companies have finalized terms for PAOG to acquire an exclusive license to a patented cannabis extraction process from PURA that will expand the PAOG’s existing CBD intellectual property. Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No....

read more

PAOG Acquisition To Expand CBD IP Portfolio Scheduled To Close December 3rd

  Sandusky, OH, Nov. 24, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the acquisition of an exclusive license to patented cannabis extraction process that will expand the company’s existing CBD intellectual property is scheduled to close next week, on Friday, December 3rd. Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). Now, the...

read more

PURA and PAOG Look To Tissue Culture Technology For Pharma Cannabis Cultivation

    Dallas, TX, Nov. 22, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) today announced plans to pursue tissue culture technology for their pharmaceutical grade cannabis cultivation initiative.  A recent announcement by Pharmagreen Biotech, Inc. got the attention of the two companies. “[PHBI] is in the business of providing the highest quality starter plantlets utilizing a proprietary tissue culture process, "Chibafreen", to licensed...

read more

PAOG Announces Pending Acquisition To Expand CBD IP Portfolio Scheduled For Early December

  Sandusky, OH, Nov. 19, 2021 -- McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today announced the company has finalized terms for the acquisition of a license to a patented cannabis extraction process that will expand the company’s existing CBD intellectual property. Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960).  Now, the company will acquire a license to...

read more

PAOG New Pharmaceutical Product Developments Could Generate Rapid Revenue Surge

  Sandusky, OH, Nov. 17, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC PINK: PAOG) today confirmed plans to add multiple new pharmaceutical products to its development pipeline in addition to its ongoing development of its RespRx CBD pharmaceutical for the treatment of Chronic Obstructive Pulmonary Disease (COPD). The company has been conducting an in-depth review of its current RespRx CBD pharmaceutical development project with its CRO partner, industry consultants and other...

read more

PURA CEO Update On Farmersville Hemp Brand Business Progress Highlighting Cannabis Real Estate Finance Offering Scheduled This Thursday, Nov 18th

Dallas, Texas, Nov. 15, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) today announced the company has scheduled a CEO update from Brian Shibley to be published this Thursday, November 18th, 2021, in conjunction with the recently published Q3 financial report. The update will provide the latest on the company’s execution of its new Farmersville Hemp Brand business model, highlighting the recently announced working relationship with UC Asset LP (OTCQX: UCASU). UCASU and PURA have...

read more

PAOG Expects To Soon Launch 3rd CBD Nutraceutical Adding To 2021 Revenue Potential

  Sandusky, OH, Nov. 09, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is on track to introduce yet a third CBD nutraceutical product by year end. PAOG recently announced the launch of its first two CBD nutraceutical products, RelaxRX CBD, a sleep aid, and RehabRX CBD, a salve. PAOG has also announced initiating a second production run of the first two CBD nutraceutical products based on the initial response to the marketing launch. PAOG has...

read more

PAOG Adds Bioidentical Synthetic CBD To Research Pipeline

  Sandusky, OH, Nov. 08, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company adding bioidentical synthetic CBD to its overall research initiative. PAOG management highlights the fact that CBD extracted from hemp, as hemp legalization continues to evolve, has certainly brought the multitude of potential health benefits from CBD to light. PAOG has a number of both CBD pharmaceutical and nutraceutical developments under way.  Now, PAOG will add bioidentical...

read more

PAOG Announces Plans To Add New Pharmaceutical Product Developments

  Sandusky, OH, Nov. 05, 2021  -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced plans to add multiple new pharmaceutical products to its development pipeline in addition to its ongoing development of its RespRx CBD pharmaceutical for the treatment of Chronic Obstructive Pulmonary Disease (COPD).   PAOG (resprx.com) The company has been conducting an in-depth review of its current RespRx CBD pharmaceutical development project with its CRO partner, industry...

read more

PURA and PAOG Partner With UCASU in Cannabis Real Estate Deal

    Dallas, TX, Nov. 03, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) today announced plans to partner with UC Asset LP (OTCQX: UCASU) in the construction of a cannabis extraction lab. UCASU and PURA have announced entering into a letter of intent outlining terms for UCASU to finance the construction of PURA’s Farmersville Hemp Brand facilities on PURA’s 72 acre property in Farmersville, Texas.  UCASU also plans to provide financing to...

read more

PAOG Announces CBD Pet Product Line To Launch In December

  Sandusky, OH, Nov. 01, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company has finalized plans to launch its CBD pet product line in December. The pet products market is estimated at over $100 billion per year. Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). PAOG is developing both pharmaceutical and nutraceutical treatments...

read more

PAOG Entertains Partnership To Accelerate Development Of CBD Pharmaceutical Treatment For $14 Billion COPD Market

  Sandusky, OH, Oct. 28, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is entertaining a partnership opportunity to accelerate the ongoing development of its RespRx CBD pharmaceutical for the treatment of Chronic Obstructive Pulmonary Disease (COPD).     The COPD treatment market is anticipated to rise from an estimated $9 billion in 2015 to $14.1 billion in 2025. Last year, PAOG acquired intellectual property derived through research into...

read more

PAOG Targets First Acquisition By Year End To Accelerate 2022 Revenue Growth

  Sandusky, OH, Oct. 26, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s merger and acquisition development pipeline supports plans for a first acquisition to close before the end of this year.  PAOG is actively exploring merger and acquisition opportunities targeted at expanding the company’s product line and accelerating revenue growth. The company recently announced initiating production on its first line of CBD nutraceuticals and being on track...

read more

PAOG Announces CBD “RX” Brand Introducing Second CBD Product

  Sandusky, OH, Oct. 21, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the launch of its second CBD nutraceutical product, RehabRX CBD, in a line of coming CBD products under the PAOG CBD “RX” brand name. RehabRX is a rich formulation with beneficial botanicals proven to support healthy skin. RehabRX is free from any preservatives, colors or flavorings. The CBD comes from hemp grown in the state of Colorado.  It is Gluten-free and Non-GMO. PAOG has shipped its...

read more

PAOG Reveals CBD Products Under Development For $100 Billion Pet Market

  Sandusky, OH, Oct. 20, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today revealed the company has been working on the development of CBD products for pets and could have its first product ready to introduce before the end of the year. The pet products market is estimated at over $100 billion per year. Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No....

read more

PAOG Scheduled To Launch 2nd CBD Nutraceutical Product This Thursday

  Sandusky, OH, Oct. 19, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) yesterday announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. The company plans to launch its second CBD nutraceutical product on Thursday this week, October 21st, 2021. PAOG is on track to realize its first revenue this year, starting in Q4 2021, since the company acquired intellectual property derived through research into CBD extracted in association with a patented...

read more

PAOG To Launch Second CBD Nutraceutical Product Later This Week Further Ramping Up 2021 Revenue Potential

  Sandusky, OH, Oct. 18, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) earlier today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. The company plans to launch its second CBD nutraceutical product later this week, On Thursday, October 21st, 2021. PAOG is on track to realize its first revenue this year, starting in Q4 2021, since the company acquired intellectual property derived through research into CBD extracted in association with a...

read more

PAOG Introduces RelaxRX CBD Targeting $100 Billion Sleep Aid Market

    Sandusky, OH, Oct. 18, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. RelaxRX is available in 30mg Softgels and in an 1800mg Tincture.  The CBD oil is 100% derived from full spectrum whole-plant hemp oil and contains no added chemicals. The sleep aid market was projected at USD 64.29 Billion in 2019 and is forecast to hit USD 101.7 Billion in 2026. PAOG has confirmed shipping...

read more

PURA and PAOG Partner On CBD Lab Construction And Hemp Cultivar Development

    Dallas, Texas, Oct. 15, 2021 -- McapMediaWire -- Puration, Inc. (OTC Pink: PURA) (“PURA”) and PAO Group, Inc.’s (OTC Pink: PAOG) (“PAOG”) today confirmed PAOG’s partnership within PURA’s new Farmersville Hemp Brand initiative. PURA is building hemp processing and cultivation partnerships with the intention of establishing an industrial hemp brand cooperative under the Farmersville Hemp Brand name.  In the fashion that Sun-Maid Raisins collectively markets for growers all selling...

read more

PAOG Announces Market Launch Of First CBD Nutraceutical To Take Place On Monday October 18th

  Sandusky, OH, Oct. 14, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the market launch of its first CBD Nutraceutical is scheduled to take place on Monday, October 18th, 2021. PAOG expects to realize its first CBD nutraceutical product sales beginning imminently in Q4, 2021. The company confirms shipping its first CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (OTC Pink: USMJ). PAOG plans to announce specifics...

read more

PAOG CBD Pharmaceutical Respiratory Treatment Research Garners New Interest

  Sandusky, OH, Oct. 13, 2021 -- McapMediaWire --  PAO Group, Inc. (OTC Pink: PAOG) today announced encountering a flurry of outside interest of late into the company’s CBD pharmaceutical respiratory treatment research.     Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). The ongoing research targets the treatment of respiratory disorders in support of a...

read more

PAOG Set To Realize First CBD Nutraceutical Sales In Q4 With Rapid Revenue Growth Expected To Follow

  Sandusky, OH, Oct. 11, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to realize its first CBD nutraceutical product sales beginning imminently in Q4, 2021. The company confirms shipping its first CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (OTC Pink: USMJ). PAOG plans to announce specifics about its first CBD nutraceutical product in an upcoming formal product launch announcement once the...

read more

PAOG Ships First CBD Nutraceutical Product To Distributor Entering $16 Billion Market

  Sandusky, OH, Oct. 07, 2021 -- McapMediaWire -- PAO Group, Inc. (OTC Pink: PAOG) today announced shipping its first CBD nutraceutical product to its distribution partner. PAOG is developing CBD pharmaceutical and nutraceuticals from its intellectual property associated with a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT." The 2020 CBD Nutraceuticals Market had an...

read more

Categories

Mcap MediaWire - Costumer Service

Translate »